Works matching IS 02780232 AND DT 2025 AND VI 43 AND IP 1

Results: 32
    1
    2
    3

    Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience.

    Published in:
    Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70028
    By:
    • Innocenti, Idanna;
    • Quaranta, Tommaso;
    • Tomasso, Annamaria;
    • Mosca, Antonio;
    • Benintende, Giulia;
    • Fresa, Alberto;
    • Larocca, Luigi Maria;
    • Stirparo, Luca;
    • Iadevaia, Francesco;
    • Vuono, Florenzia;
    • Bellesi, Silvia;
    • Bakacs, Arianna;
    • Efremov, Dimitar;
    • Gattei, Valter;
    • Giannarelli, Diana;
    • Autore, Francesco;
    • Laurenti, Luca
    Publication type:
    Article
    4
    5
    6

    Comprehensive Characterization of Overt Myelofibrosis in an Asian Cohort: Phenotype, Mutation Landscape and Discordance Among Scoring Systems.

    Published in:
    Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70040
    By:
    • Chang, Yu‐Sung;
    • Wang, Yu‐Hung;
    • Wei, Chao‐Hung;
    • Chen, Yu‐Wen;
    • Lin, Hsing‐Yu;
    • Lin, Chien‐Chin;
    • Tsai, Xavier Cheng‐Hong;
    • Yuan, Chang‐Tsu;
    • Tien, Feng‐Ming;
    • Lin, Yun‐Chu;
    • Lee, Sze‐Hwei;
    • Kuo, Yuan‐Yeh;
    • Chuang, Ming‐Kai;
    • Ko, Bor‐Sheng;
    • Yao, Ming;
    • Tien, Hwei‐Fang;
    • Chou, Wen‐Chien;
    • Hou, Hsin‐An
    Publication type:
    Article
    7
    8
    9
    10

    MicroRNA Profiling of Bone Marrow Plasma Extracellular Vesicles in Multiple Myeloma, Extramedullary Disease, and Plasma Cell Leukemia.

    Published in:
    Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70036
    By:
    • Gregorova, Jana;
    • Vlachova, Monika;
    • Vychytilova‐Faltejskova, Petra;
    • Dostalova, Adela;
    • Ruzickova, Tereza;
    • Vecera, Marek;
    • Radova, Lenka;
    • Pospichalova, Vendula;
    • Sladecek, Stanislava;
    • Hyzdalova, Martina;
    • Kotaskova, Jana;
    • Jarosova, Marie;
    • Masek, Josef;
    • Benesova, Klara;
    • Jarkovsky, Jiri;
    • Rihova, Lucie;
    • Bezdekova, Renata;
    • Almasi, Martina;
    • Boichuk, Ivanna;
    • Stork, Martin
    Publication type:
    Article
    11
    12

    Acalabrutinib in High‐Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real‐Life Experience.

    Published in:
    Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70033
    By:
    • Innocenti, Idanna;
    • Tomasso, Annamaria;
    • Giannarelli, Diana;
    • Scarfò, Lydia;
    • Murru, Roberta;
    • Visentin, Andrea;
    • Frustaci, Anna Maria;
    • Morelli, Francesca;
    • Vitale, Candida;
    • Mosca, Antonio;
    • Sanna, Alessandro;
    • Farina, Giuliana;
    • Laureana, Roberta;
    • Gentile, Massimo;
    • Galitzia, Andrea;
    • Pasquale, Raffaella;
    • Autore, Francesco;
    • Olivieri, Jacopo;
    • Romeo, Azzurra;
    • Deodato, Marina
    Publication type:
    Article
    13

    Issue Information.

    Published in:
    Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70011
    Publication type:
    Article
    14

    Molecular Profiling Identifies CD49d and CD79b as Predictive Markers for Acquired Acalabrutinib Resistance in Patients With Chronic Lymphocytic Leukemia.

    Published in:
    Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70008
    By:
    • Bibikova, Elena;
    • Parsa, Sara;
    • Floren, Muskan;
    • Law, Brian;
    • Clevenger, Tracy;
    • Cheung, Jean;
    • De Jesus, Gary;
    • Burke, Kathleen;
    • Gulrajani, Michael;
    • Yamaguchi, Kyoko;
    • Do, Phuong;
    • Dougherty, Brian;
    • Whitston, David;
    • Brock, Graham;
    • Munugalavadla, Veerendra;
    • Frigault, Melanie M.;
    • Hartmann, Tanja N.;
    • Byrd, John C.;
    • Furman, Richard R.;
    • Brown, Jennifer R.
    Publication type:
    Article
    15

    Impact of C‐MYC/BCL2 Double Expression on Survival Outcomes After Autologous Transplantation in Relapsed/Refractory Diffuse Large B Cell Lymphoma—A Nationwide Retrospective Analysis in Singapore.

    Published in:
    Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70030
    By:
    • Tan, Jing Yuan;
    • Ling, Victor Wei Teik;
    • Ng, Lawrence Cheng Kiat;
    • Krisnadi, Cindy;
    • Tan, Melinda Si Yuan;
    • Grigoropoulos, Nicholas Francis;
    • Ong, Shin Yeu;
    • Nagarajan, Chandramouli;
    • Quek, Jeffrey Kim Siang;
    • Than, Hein;
    • Lee, Joanne;
    • Chan, Esther;
    • Tan, Lip Kun;
    • Hwang, William Ying Khee;
    • Goh, Yeow Tee;
    • Linn, Yeh Ching;
    • Koh, Liang Piu;
    • Ho, Aloysius Yew Leng;
    • Lim, Francesca Wei Inng;
    • Poon, Michelle Limei
    Publication type:
    Article
    16
    17
    18
    19
    20

    In Situ Tracking of TCRβ Isoforms for Detection of T Cell Clonality: Implication for Precision Diagnosis and Targeted Immunotherapy of T‐Cell Neoplasms.

    Published in:
    Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70018
    By:
    • Manipadam, Marie Therese;
    • Marra, Andrea;
    • Ramsay, Alan;
    • Padmasri, Sugerdana;
    • Gosh, Adheesh;
    • Neves, Margarida;
    • Bailey, Chris;
    • Pomplun, Sabine;
    • Maciocia, Paul;
    • Cwynarski, Kate;
    • Ferrari, Mathieu;
    • Lao‐Siriex, Pierre;
    • Piris, Miguel;
    • Falini, Brunangelo;
    • Linch, David;
    • Rosenwald, Andreas;
    • Pule, Martin;
    • Zamò, Alberto;
    • Marafioti, Teresa
    Publication type:
    Article
    21

    Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B‐Cell Lymphoma: A Real‐World, Multi‐Center, Retrospective Cohort Study.

    Published in:
    Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70017
    By:
    • Zhao, Peiqi;
    • Zhao, Shu;
    • Huang, Chen;
    • Li, Yajun;
    • Wang, Jiesong;
    • Xu, Junqing;
    • Li, Lanfang;
    • Qian, Zhengzi;
    • Li, Wei;
    • Zhou, Shiyong;
    • Qiu, Lihua;
    • Liu, Xianming;
    • Chen, Ying;
    • Jiang, Yanan;
    • Zheng, Yanbin;
    • Chen, Daoguang;
    • Zhou, Hui;
    • Gao, Yuhuan;
    • Zhang, Qingyuan;
    • Zhang, Huilai
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29

    Molecular Features of Diffuse Large B‐Cell Lymphoma Associated With Primary Treatment Resistance.

    Published in:
    Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70006
    By:
    • Bock, Allison M.;
    • Wenzl, Kerstin;
    • Novak, Joseph P.;
    • Stokes, Matthew E.;
    • Hopper, Melissa A.;
    • Krull, Jordan E.;
    • Dropik, Abigail R.;
    • Sarangi, Vivek;
    • Ortiz, Maria;
    • Stong, Nicholas;
    • Huang, C. Chris;
    • Maurer, Matthew J.;
    • King, Rebecca L.;
    • Farooq, Umar;
    • Wang, Yucai;
    • Witzig, Thomas E.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Cerhan, James R.;
    • Gandhi, Anita K.
    Publication type:
    Article
    30

    Comparing Outcomes Between CPX‐351 and Fludarabine‐Based Induction in Secondary Acute Myeloid Leukemia in the Real‐World Setting: The Prognostic Role of Measurable Residual Disease.

    Published in:
    Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70005
    By:
    • Riva, Carola;
    • Minetto, Paola;
    • Chies, Maria;
    • Vernarecci, Chiara;
    • Colombo, Nicoletta;
    • Rosellini, Sara;
    • Parodi, Alessia;
    • Tedone, Elisabetta;
    • Carminati, Enrico;
    • Nurra, Clara;
    • Puglisi, Francesco;
    • Frello, Michela;
    • Maio, Elena;
    • Ferro, Beatrice;
    • Zecchetti, Giada;
    • Fugazza, Giuseppina;
    • Nozza, Paolo;
    • Cea, Michele;
    • Lemoli, Roberto Massimo;
    • Guolo, Fabio
    Publication type:
    Article
    31
    32